Skip to main content

Table 1 Patients’ demographics and preoperative characteristics

From: Higher incidence of perivalvular abscess determines perioperative clinical outcome in patients undergoing surgery for prosthetic valve endocarditis

 

ENTIRE COHORT

PROPENSITY MATCHED COHORT

NVE (n = 315)

PVE (n = 103)

P value

NVE (n = 79)

PVE (n = 79)

P value

Age

62.7

[49.4–71.6]

71.5

[62.0–76.6]

< 0.001

65.5

[55.5–72.2]

69.2

[55.5–75.5]

0.204

Female sex

71

(22.5%)

33

(32.0%)

0.046

22

(27.8%)

19

(24.1%)

0.586

BMI

25.5

[23.2–28.1]

26.0

[23.9–28.7]

0.273

25.4

[23.7–28.8]

26.1

[23.9–28.7]

0.548

BSA

1.98

[1.83–2.12]

1.94

[1.74–2.10]

0.238

1.97

± 0.21

1.97

± 0.24

0.349

COPD

29

(9.2%)

9

(8.7%)

0.886

10

(12.7%)

8

(10.1%)

0.617

Diabetes

81

(25.7%)

34

(33.0%)

0.150

21

(26.6%)

25

(31.6%)

0.484

Peripheral vascular disease

23

(7.3%)

12

(11.7%)

0.167

6

(7.6%)

7

(8.9%)

0.772

Preoperative AKI

173

(54.9%)

69

(67.0%)

0.031

54

(68.4%)

52

(65.8%)

0.735

Preoperative dialysis

30

(9.5%)

13

(12.6%)

0.889

6

(7.6%)

13

(16.5%)

0.176

Coronary artery disease

80

(25.4%)

36

(35.5%)

0.060

23

(29.1%)

22

(27.8%)

0.860

Prior PCI

18

(5.7%)

14

(13.6%)

0.054

4

(5.1%)

8

(10.1%)

0.124

Immunosuppression

5

(1.6%)

2

(1.9%)

0.811

1

(1.3%)

1

(1.3%)

1.000

HIV

9

(2.9%)

1

(1.0%)

0.233

0

(0%)

1

(1.3%)

0.238

Alcohol abuse

37

(11.7%)

4

(3.9%)

0.020

8

(10.1%)

3

(3.8%)

0.118

Intravenous drug abuse

22

(7.0%)

6

(5.8%)

0.683

5

(6.3%)

6

(7.6%)

0.755

History of neoplasm

33

(10.5%)

10

(9.7%)

0.824

12

(15.2%)

6

(7.6%)

0.133

LVEF

  < 30%

7

(2.2%)

2

(1.9%)

0.865

1

(1.3%)

2

(2.5%)

0.559

 30–50%

63

(20%)

30

(29.1%)

0.532

16

(20.3%)

23

(29.1%)

0.268

  > 50%

238

(75.6%)

70

(70.0%)

0.129

62

(78.5%)

53

(67.1%)

0.108

NYHA class

 I + II

55

(17.5%)

19

(18.4%)

0.925

20

(25.3%)

14

(17.7%)

0.245

 III + IV

251

(80.0%)

80

(77.7%)

0.662

59

(74.7%)

63

(79.7%)

0.448

 Log. EuroSCORE

7.6

[4.4–18.1]

9.8

[22.3–36.2]

< 0.001

7.9

[4.1–16.3]

17.5

[7.9–33.7]

< 0.001

 EuroSCORE II

7.0

[5.0–10.0]

11.0

[8.0–13.0]

< 0.001

7.0

[5.0–9.0]

10.0

[7.0–12.3]

< 0.001

  1. Data presented as mean ± standard deviation, number (percent) or median [IQR], respectively. AKI, acute kidney injury; BMI, body mass index; BSA, body surface area; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; IQR, interquartile range; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; TIA, transient ischemic attack
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us